Type 2 diabetes is driven by insulin resistance and pancreatic cell dysfunction
Address underlying conditions Treatment depends entirely on the identified cause: Liver disease: Management according to aetiology (alcohol cessation, antiviral therapy for hepatitis, treatment of non-alcoholic fatty liver disease)
As research progresses, regulated pharmaceutical development may eventually offer validated pathways for NNMT inhibitors
B12 is added to the mix because it supports energy production and red blood cell formation
If you are deficient in B12, a course of injections or high dose oral supplementation may be advised
Patients with thrombocytopenia due to an underlying disease or condition will also be managed by the specialists that treat these underlying conditions, including infectious disease specialists, rheumatologists, oncologists, and others